Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
January 15, 2001
Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2
P W Bergum, A Cruikshank, S L Maki, et al.
Circulation
|
February 1, 1992
Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis
G R Sitko, D R Ramjit, I I Stabilito, et al.
Journal of Pharmacological and Toxicological Methods
|
February 1, 1995
Effect of inhibitors of factor Xa or platelet adhesion, heparin, and aspirin on platelet deposition in an atherosclerotic rabbit model of angioplasty injury
E M Lyle, T Fujita, M W Conner, et al.
Protein Science : a Publication of the Protein Society
|
February 1, 1995
NMR structure determination of tick anticoagulant peptide (TAP)
M S Lim-Wilby, K Hallenga, M de Maeyer, et al.
Biochemistry
|
February 16, 1982
Multiplicity strain differences, and topology of phenobarbital-induced cytochromes P-450 in rat liver microsomes
G P Vlasuk, J Ghrayeb, D E Ryan, et al.
Circulation
|
January 1, 1996
Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis
B J Biemond, P W Friederich, M Levi, et al.
Protein Science : a Publication of the Protein Society
|
March 1, 1996
Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic
R Krishnan, A Tulinsky, G P Vlasuk, et al.
Thrombosis and Haemostasis
|
March 4, 1991
Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and tick anticoagulant peptide (TAP) in a rabbit model of venous thrombosis
G P Vlasuk, D Ramjit, T Fujita, et al.
The Journal of Biological Chemistry
|
April 25, 1982
Multiple, immunoidentical forms of phenobarbital-induced rat liver cytochromes P-450 are encoded by different mRNAs
F G Walz, G P Vlasuk, C J Omiecinski, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 16, 2008
Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis
J K Hennan, G A Morgan, R E Swillo, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
January 15, 2001
Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2
P W Bergum, A Cruikshank, S L Maki, et al.
Circulation
|
February 1, 1992
Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis
G R Sitko, D R Ramjit, I I Stabilito, et al.
Journal of Pharmacological and Toxicological Methods
|
February 1, 1995
Effect of inhibitors of factor Xa or platelet adhesion, heparin, and aspirin on platelet deposition in an atherosclerotic rabbit model of angioplasty injury
E M Lyle, T Fujita, M W Conner, et al.
Protein Science : a Publication of the Protein Society
|
February 1, 1995
NMR structure determination of tick anticoagulant peptide (TAP)
M S Lim-Wilby, K Hallenga, M de Maeyer, et al.
Biochemistry
|
February 16, 1982
Multiplicity strain differences, and topology of phenobarbital-induced cytochromes P-450 in rat liver microsomes
G P Vlasuk, J Ghrayeb, D E Ryan, et al.
Circulation
|
January 1, 1996
Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis
B J Biemond, P W Friederich, M Levi, et al.
Protein Science : a Publication of the Protein Society
|
March 1, 1996
Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic
R Krishnan, A Tulinsky, G P Vlasuk, et al.
Thrombosis and Haemostasis
|
March 4, 1991
Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and tick anticoagulant peptide (TAP) in a rabbit model of venous thrombosis
G P Vlasuk, D Ramjit, T Fujita, et al.
The Journal of Biological Chemistry
|
April 25, 1982
Multiple, immunoidentical forms of phenobarbital-induced rat liver cytochromes P-450 are encoded by different mRNAs
F G Walz, G P Vlasuk, C J Omiecinski, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 16, 2008
Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis
J K Hennan, G A Morgan, R E Swillo, et al.
Page
of 7